Endothelial dysfunction and oxidative stress in children with sleep disordered breathing: Role of NADPH oxidase

Atherosclerosis

Volumn 240, Issue 1, 2015, Pages 222-227

  Loffredo, Lorenzo ^a   Zicari, Anna Maria ^a   Occasi, Francesca ^a   Perri, Ludovica ^a   Carnevale, Roberto ^a   Angelico, Francesco ^a   Del Ben, Maria ^a   Martino, Francesco ^a   Nocella, Cristina ^a   Savastano, Vincenzo ^a   Cesoni Marcelli, Azzurra ^a   Duse, Marzia ^a   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Atherosclerosis; Endothelial function; Oxidative stress; Sleep disorder breathing

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; CHOLESTEROL; GLUCOSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; 8-EPI-PROSTAGLANDIN F2ALPHA; BIOLOGICAL MARKER; CYBB PROTEIN, HUMAN; MEMBRANE PROTEIN; PROSTAGLANDIN F2 ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADENOTONSILLAR HYPERTROPHY; ADENOTONSILLECTOMY; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CHILD; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; FEMALE; FLOW MEDIATED DILATION; GAS EXCHANGE; GLUCOSE BLOOD LEVEL; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PEDIATRIC SURGERY; POLYSOMNOGRAPHY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SLEEP DISORDERED BREATHING; SNORING; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VASODILATATION; ADENOIDECTOMY; AGE; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; ENZYMOLOGY; ITALY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SIGNAL TRANSDUCTION; SLEEP APNEA SYNDROMES; TIME; TONSILLECTOMY; VASCULAR ENDOTHELIUM;

ADENOIDECTOMY; AGE FACTORS; BIOMARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DINOPROST; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; OXIDATIVE STRESS; ROME; SIGNAL TRANSDUCTION; SLEEP APNEA SYNDROMES; TIME FACTORS; TONSILLECTOMY; TREATMENT OUTCOME;

EID: 84925065014     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.03.024     Document Type: Article

References (41)

1. Charakida M., Masi S., Luscher T.F., et al. Assessment of atherosclerosis: the role of flow-mediated dilatation. Eur. Heart J. 2010, 31:2854-2861.
2. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J.Am. Coll. Cardiol. 2002, 39:257-265.
3. Au C.T., Li A.M. Obstructive sleep breathing disorders. Pediatr. Clin. North Am. 2009, 56:243-259. xii.
4. Marcus C.L., Brooks L.J., Draper K.A., et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2012, 130:e714-755.
5. Li A.M., Au C.T., Chook P., et al. Reduced flow-mediated vasodilation of brachial artery in children with primary snoring. Int. J. Cardiol. 2013, 167:2092-2096.
6. Carra M.C., Bruni O., Huynh N. Topical review: sleep bruxism, headaches, and sleep-disordered breathing in children and adolescents. J.Orofac. Pain 2012, 26:267-276.
7. Kwok K.L., Ng D.K., Cheung Y.F. BP and arterial distensibility in children with primary snoring. Chest 2003, 123:1561-1566.
8. Kheirandish-Gozal L., Bhattacharjee R., Gozal D. Autonomic alterations and endothelial dysfunction in pediatric obstructive sleep apnea. Sleep. Med. 2010, 11:714-720.
9. Vlahandonis A., Walter L.M., Horne R.S. Does treatment of SDB in children improve cardiovascular outcome?. Sleep. Med. Rev. 2013, 17:75-85.
10. Ross R. Atherosclerosis-an inflammatory disease. N.Engl. J. Med. 1999, 340:115-126.
11. Violi F., Marino R., Milite M.T., et al. Nitric oxide and its role in lipid peroxidation. Diabetes Metab. Res. Rev. 1999, 15:283-288.
12. Violi F., Sanguigni V., Carnevale R., et al. Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study. Circulation 2009, 120:1616-1622.
13. Loffredo L., Carnevale R., Sanguigni V., et al. Does NADPH oxidase deficiency cause artery dilatation in humans?. Antioxid. Redox Signal 2013, 18:1491-1496.
14. Cave A.C., Brewer A.C., Narayanapanicker A., et al. NADPH oxidases in cardiovascular health and disease. Antioxid. Redox Signal 2006, 8:691-728.
15. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007, 87:245-313.
16. Gozal D., Kheirandish L. Oxidant stress and inflammation in the snoring child: confluent pathways to upper airway pathogenesis and end-organ morbidity. Sleep. Med. Rev. 2006, 10:83-96.
17. Villa M.P., Supino M.C., Fedeli S., et al. Urinary concentration of 8-isoprostane as marker of severity of pediatric OSAS. Sleep. Breath. 2014, 18:23-29.
18. Gozal D., Kheirandish-Gozal L., Bhattacharjee R., et al. Neurocognitive and endothelial dysfunction in children with obstructive sleep apnea. Pediatrics 2010, 126:e1161-e1167.
19. Montgomery-Downs H.E., Krishna J., Roberts L.J., et al. Urinary F2-isoprostane metabolite levels in children with sleep-disordered breathing. Sleep. Breath. 2006, 10:211-215.
20. Pringle M.B., Natesh B.G., Buchanan E.M. National UK survey on the assessment and surgical management of suspected paediatric obstructive sleep apnoea syndrome. Int. J. Pediatr. Otorhinolaryngology 2013, 77:1689-1696.
21. Ng D.K., Chow P.Y., Chan C.H., et al. An update on childhood snoring. Acta Paediatr. 2006, 95:1029-1035.
22. Marcus C.L., Moore R.H., Rosen C.L., et al. Arandomized trial of adenotonsillectomy for childhood sleep apnea. N.Engl. J. Med. 2013, 368:2366-2376.
23. Brouilette R., Hanson D., David R., et al. Adiagnostic approach to suspected obstructive sleep apnea in children. J.Pediatr. 1984, 105:10-14.
24. Carroll J.L., McColley S.A., Marcus C.L., et al. Inability of clinical history to distinguish primary snoring from obstructive sleep apnea syndrome in children. Chest 1995, 108:610-618.
25. Cassano P., Gelardi M., Cassano M., et al. Adenoid tissue rhinopharyngeal obstruction grading based on fiberendoscopic findings: a novel approach to therapeutic management. Int. J. Pediatr. Otorhinolaryngol. 2003, 67:1303-1309.
26. Brodsky L., Moore L., Stanievich J.F. Acomparison of tonsillar size and oropharyngeal dimensions in children with obstructive adenotonsillar hypertrophy. Int. J. Pediatr. Otorhinolaryngol. 1987, 13:149-156.
27. Zicari A.M., Cutrera R., Occasi F., et al. Serum resistin levels in children with primary snoring. Int. J. Immunopathol. Pharmacol. 2014, 27:449-454.
28. Zicari A.M., Duse M., Occasi F., et al. Cephalometric pattern and nasal patency in children with primary snoring: the evidence of a direct correlation. PLoS One 2014, 9:e111675.
29. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J.Am. Coll. Cardiol. 2002, 39:257-265.
30. Loffredo L., Marcoccia A., Pignatelli P., et al. Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease. Eur. Heart J. 2007, 28:608-612.
31. Freestone B., Chong A.Y., Nuttall S., et al. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels. Thrombosis Res. 2008, 122:85-90.
32. Pignatelli P., Carnevale R., Cangemi R., et al. Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 2010, 30:360-367.
33. Hoffman S.W., Roof R.L., Stein D.G. Areliable and sensitive enzyme immunoassay method for measuring 8-isoprostaglandin F2 alpha: a marker for lipid peroxidation after experimental brain injury. J.Neurosci. Methods 1996, 68:133-136.
34. Loffredo L., Martino F., Carnevale R., et al. Obesity and hypercholesterolemia are associated with NOX2 generated oxidative stress and arterial dysfunction. J.Pediatr. 2012, 161:1004-1009.
35. Martino F., Loffredo L., Carnevale R., et al. Oxidative stress is associated with arterial dysfunction and enhanced intima-media thickness in children with hypercholesterolemia: the potential role of nicotinamide-adenine dinucleotide phosphate oxidase. Pediatrics 2008, 122:e648-655.
36. Biggs S.N., Nixon G.M., Horne R.S. The conundrum of primary snoring in children: what are we missing in regards to cognitive and behavioural morbidity?. Sleep. Med. Rev. 2014, 18:463-475.
37. Celik M., Tuncer A., Soyer O.U., et al. Oxidative stress in the airways of children with asthma and allergic rhinitis. Pediatr. Allergy Immunol. Off. Publ. Eur. Soc. Pediatr. Allergy Immunol. 2012, 23:556-561.
38. Wan G.H., Yan D.C., Tseng H.Y., et al. Cysteinyl leukotriene levels correlate with 8-isoprostane levels in exhaled breath condensates of atopic and healthy children. Pediatr. Res. 2013, 74:584-591.
39. Del Ben M., Fabiani M., Loffredo L., et al. Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment. BMC Pulm. Med. 2012, 12:36.
40. Fava C., Montagnana M., Favaloro E.J., et al. Obstructive sleep apnea syndrome and cardiovascular diseases. Semin. Thromb. Hemost. 2011, 37:280-297.
41. Chan K.C., Au C.T., Chook P., et al. Endothelial function in children with OSA and the effects of adenotonsillectomy. Chest 2015, 147:132-139.